Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain–loss of function of pentraxin 3 and matrix metalloproteinase 12
Objective Studies have shown that in systemic sclerosis (SSc) endothelial cells, overproduction of matrix metalloproteinase 12 (MMP‐12) and pentraxin 3 (PTX3) is associated with defective angiogenesis. This study was undertaken to examine whether overexpression of the relevant molecules could inhibi...
Gespeichert in:
Veröffentlicht in: | Arthritis and rheumatism 2010-08, Vol.62 (8), p.2488-2498 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2498 |
---|---|
container_issue | 8 |
container_start_page | 2488 |
container_title | Arthritis and rheumatism |
container_volume | 62 |
creator | Margheri, Francesca Serratì, Simona Lapucci, Andrea Chillà, Anastasia Bazzichi, Laura Bombardieri, Stefano Kahaleh, Bashar Calorini, Lido Bianchini, Francesca Fibbi, Gabriella Del Rosso, Mario |
description | Objective
Studies have shown that in systemic sclerosis (SSc) endothelial cells, overproduction of matrix metalloproteinase 12 (MMP‐12) and pentraxin 3 (PTX3) is associated with defective angiogenesis. This study was undertaken to examine whether overexpression of the relevant molecules could inhibit angiogenesis of normal microvascular endothelial cells (MVECs), and whether silencing of these molecules in SSc MVECs could restore the lost angiogenic properties of the cells in vitro and in vivo.
Methods
Transient transfection of MVECs with human MMP12 and PTX3 was performed by electroporation. Silencing of MMP12 and PTX3 was obtained by treatment with small interfering RNA, and treatment effects were validated by Western blotting with specific antibodies and a fluorimetric assay. In vitro cell migration and capillary morphogenesis were studied on Matrigel substrates. In vivo angiogenesis was studied using a Matrigel sponge assay in mice.
Results
Transfection of MMP12 and PTX3 in normal MVECs resulted in loss of proliferation, invasion, and capillary morphogenesis in vitro, attributed to truncation of the urokinase‐type plasminogen activator receptor by MMP12 and to the anti–fibroblast growth factor 2/anti–vascular endothelial growth factor activity of PTX3. These effects were particularly evident in mixed populations of transfected normal MVECs (50% transfected with MMP12 and 50% with PTX3). Silencing of the same molecules in SSc MVECs increased their invasion in Matrigel. Single‐gene silencing did not increase the capillary morphogenesis of SSc MVECs, whereas double‐gene–silenced cells showed a burst of capillary tube formation. Culture medium of silenced SSc MVECs stimulated angiogenesis in assays of Matrigel sponge invasion in mice.
Conclusion
Overexpression of either MMP12 or PTX3 in normal MVECs blunts their angiogenic properties. Loss of function of MMP12 and PTX3 in SSc MVECs restores the ability of the cells to produce capillaries in vitro and induces vascularization in vivo on a Matrigel sponge. |
doi_str_mv | 10.1002/art.27522 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_748940805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748940805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4552-346ef0076f549a18a26f97ae284ede68174cdcd321470b5b4a51531c8988c8b43</originalsourceid><addsrcrecordid>eNp1kc1u1TAQhS1ERS-FBS-AvEGIRVr_Js6yqviTWlVCZR05zuTWyLGD7YhmxzvwCLwZT4Jv721ZsRqN5ptzdHQQekXJKSWEnemYT1kjGXuCNlSytiKU06doQwgRFZctPUbPU_pWVsYlf4aOGZGkJm27Qb-vwrA4nW3wOIw43wLWfmvDFrw1eL4FH_I6w-7mQ5y0K-cBpzVlmAqQjIMYkk0Y_BDKt7MFMeBcwv2Kt9r6Pz9_uZDSTmFcvHlwmsHnqO-sx_xectI52js8QdbOhTmGDNbrBJiyF-ho1C7By8M8QV8_vL-5-FRdXn_8fHF-WRkhJau4qGEkpKlHKVpNlWb12DYamBIwQK1oI8xgBs6oaEgve6EllZwa1SplVC_4CXq71y3u3xdIuZts2mXRHsKSukaoVhBFZCHf7UlTwqcIYzdHO-m4dpR0u0q6Ukl3X0lhXx9Ul36C4ZF86KAAbw6ATka7MWpvbPrHccoVq5vCne25H9bB-n_H7vzLzd76L32npi0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748940805</pqid></control><display><type>article</type><title>Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain–loss of function of pentraxin 3 and matrix metalloproteinase 12</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Margheri, Francesca ; Serratì, Simona ; Lapucci, Andrea ; Chillà, Anastasia ; Bazzichi, Laura ; Bombardieri, Stefano ; Kahaleh, Bashar ; Calorini, Lido ; Bianchini, Francesca ; Fibbi, Gabriella ; Del Rosso, Mario</creator><creatorcontrib>Margheri, Francesca ; Serratì, Simona ; Lapucci, Andrea ; Chillà, Anastasia ; Bazzichi, Laura ; Bombardieri, Stefano ; Kahaleh, Bashar ; Calorini, Lido ; Bianchini, Francesca ; Fibbi, Gabriella ; Del Rosso, Mario</creatorcontrib><description>Objective
Studies have shown that in systemic sclerosis (SSc) endothelial cells, overproduction of matrix metalloproteinase 12 (MMP‐12) and pentraxin 3 (PTX3) is associated with defective angiogenesis. This study was undertaken to examine whether overexpression of the relevant molecules could inhibit angiogenesis of normal microvascular endothelial cells (MVECs), and whether silencing of these molecules in SSc MVECs could restore the lost angiogenic properties of the cells in vitro and in vivo.
Methods
Transient transfection of MVECs with human MMP12 and PTX3 was performed by electroporation. Silencing of MMP12 and PTX3 was obtained by treatment with small interfering RNA, and treatment effects were validated by Western blotting with specific antibodies and a fluorimetric assay. In vitro cell migration and capillary morphogenesis were studied on Matrigel substrates. In vivo angiogenesis was studied using a Matrigel sponge assay in mice.
Results
Transfection of MMP12 and PTX3 in normal MVECs resulted in loss of proliferation, invasion, and capillary morphogenesis in vitro, attributed to truncation of the urokinase‐type plasminogen activator receptor by MMP12 and to the anti–fibroblast growth factor 2/anti–vascular endothelial growth factor activity of PTX3. These effects were particularly evident in mixed populations of transfected normal MVECs (50% transfected with MMP12 and 50% with PTX3). Silencing of the same molecules in SSc MVECs increased their invasion in Matrigel. Single‐gene silencing did not increase the capillary morphogenesis of SSc MVECs, whereas double‐gene–silenced cells showed a burst of capillary tube formation. Culture medium of silenced SSc MVECs stimulated angiogenesis in assays of Matrigel sponge invasion in mice.
Conclusion
Overexpression of either MMP12 or PTX3 in normal MVECs blunts their angiogenic properties. Loss of function of MMP12 and PTX3 in SSc MVECs restores the ability of the cells to produce capillaries in vitro and induces vascularization in vivo on a Matrigel sponge.</description><identifier>ISSN: 0004-3591</identifier><identifier>EISSN: 1529-0131</identifier><identifier>DOI: 10.1002/art.27522</identifier><identifier>PMID: 20506099</identifier><identifier>CODEN: ARHEAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Blotting, Western ; C-Reactive Protein - genetics ; C-Reactive Protein - metabolism ; Cell Movement - physiology ; Cell Proliferation ; Diseases of the osteoarticular system ; Endothelial Cells - metabolism ; Endothelium, Vascular - cytology ; Endothelium, Vascular - metabolism ; Humans ; Matrix Metalloproteinase 12 - genetics ; Matrix Metalloproteinase 12 - metabolism ; Medical sciences ; Neovascularization, Pathologic - metabolism ; Neovascularization, Physiologic - physiology ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Scleroderma, Systemic - metabolism ; Serum Amyloid P-Component - genetics ; Serum Amyloid P-Component - metabolism ; Transfection</subject><ispartof>Arthritis and rheumatism, 2010-08, Vol.62 (8), p.2488-2498</ispartof><rights>Copyright © 2010 by the American College of Rheumatology</rights><rights>2015 INIST-CNRS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4552-346ef0076f549a18a26f97ae284ede68174cdcd321470b5b4a51531c8988c8b43</citedby><cites>FETCH-LOGICAL-c4552-346ef0076f549a18a26f97ae284ede68174cdcd321470b5b4a51531c8988c8b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fart.27522$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fart.27522$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23138267$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20506099$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Margheri, Francesca</creatorcontrib><creatorcontrib>Serratì, Simona</creatorcontrib><creatorcontrib>Lapucci, Andrea</creatorcontrib><creatorcontrib>Chillà, Anastasia</creatorcontrib><creatorcontrib>Bazzichi, Laura</creatorcontrib><creatorcontrib>Bombardieri, Stefano</creatorcontrib><creatorcontrib>Kahaleh, Bashar</creatorcontrib><creatorcontrib>Calorini, Lido</creatorcontrib><creatorcontrib>Bianchini, Francesca</creatorcontrib><creatorcontrib>Fibbi, Gabriella</creatorcontrib><creatorcontrib>Del Rosso, Mario</creatorcontrib><title>Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain–loss of function of pentraxin 3 and matrix metalloproteinase 12</title><title>Arthritis and rheumatism</title><addtitle>Arthritis Rheum</addtitle><description>Objective
Studies have shown that in systemic sclerosis (SSc) endothelial cells, overproduction of matrix metalloproteinase 12 (MMP‐12) and pentraxin 3 (PTX3) is associated with defective angiogenesis. This study was undertaken to examine whether overexpression of the relevant molecules could inhibit angiogenesis of normal microvascular endothelial cells (MVECs), and whether silencing of these molecules in SSc MVECs could restore the lost angiogenic properties of the cells in vitro and in vivo.
Methods
Transient transfection of MVECs with human MMP12 and PTX3 was performed by electroporation. Silencing of MMP12 and PTX3 was obtained by treatment with small interfering RNA, and treatment effects were validated by Western blotting with specific antibodies and a fluorimetric assay. In vitro cell migration and capillary morphogenesis were studied on Matrigel substrates. In vivo angiogenesis was studied using a Matrigel sponge assay in mice.
Results
Transfection of MMP12 and PTX3 in normal MVECs resulted in loss of proliferation, invasion, and capillary morphogenesis in vitro, attributed to truncation of the urokinase‐type plasminogen activator receptor by MMP12 and to the anti–fibroblast growth factor 2/anti–vascular endothelial growth factor activity of PTX3. These effects were particularly evident in mixed populations of transfected normal MVECs (50% transfected with MMP12 and 50% with PTX3). Silencing of the same molecules in SSc MVECs increased their invasion in Matrigel. Single‐gene silencing did not increase the capillary morphogenesis of SSc MVECs, whereas double‐gene–silenced cells showed a burst of capillary tube formation. Culture medium of silenced SSc MVECs stimulated angiogenesis in assays of Matrigel sponge invasion in mice.
Conclusion
Overexpression of either MMP12 or PTX3 in normal MVECs blunts their angiogenic properties. Loss of function of MMP12 and PTX3 in SSc MVECs restores the ability of the cells to produce capillaries in vitro and induces vascularization in vivo on a Matrigel sponge.</description><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>C-Reactive Protein - genetics</subject><subject>C-Reactive Protein - metabolism</subject><subject>Cell Movement - physiology</subject><subject>Cell Proliferation</subject><subject>Diseases of the osteoarticular system</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelium, Vascular - cytology</subject><subject>Endothelium, Vascular - metabolism</subject><subject>Humans</subject><subject>Matrix Metalloproteinase 12 - genetics</subject><subject>Matrix Metalloproteinase 12 - metabolism</subject><subject>Medical sciences</subject><subject>Neovascularization, Pathologic - metabolism</subject><subject>Neovascularization, Physiologic - physiology</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Scleroderma, Systemic - metabolism</subject><subject>Serum Amyloid P-Component - genetics</subject><subject>Serum Amyloid P-Component - metabolism</subject><subject>Transfection</subject><issn>0004-3591</issn><issn>1529-0131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1TAQhS1ERS-FBS-AvEGIRVr_Js6yqviTWlVCZR05zuTWyLGD7YhmxzvwCLwZT4Jv721ZsRqN5ptzdHQQekXJKSWEnemYT1kjGXuCNlSytiKU06doQwgRFZctPUbPU_pWVsYlf4aOGZGkJm27Qb-vwrA4nW3wOIw43wLWfmvDFrw1eL4FH_I6w-7mQ5y0K-cBpzVlmAqQjIMYkk0Y_BDKt7MFMeBcwv2Kt9r6Pz9_uZDSTmFcvHlwmsHnqO-sx_xectI52js8QdbOhTmGDNbrBJiyF-ho1C7By8M8QV8_vL-5-FRdXn_8fHF-WRkhJau4qGEkpKlHKVpNlWb12DYamBIwQK1oI8xgBs6oaEgve6EllZwa1SplVC_4CXq71y3u3xdIuZts2mXRHsKSukaoVhBFZCHf7UlTwqcIYzdHO-m4dpR0u0q6Ukl3X0lhXx9Ul36C4ZF86KAAbw6ATka7MWpvbPrHccoVq5vCne25H9bB-n_H7vzLzd76L32npi0</recordid><startdate>201008</startdate><enddate>201008</enddate><creator>Margheri, Francesca</creator><creator>Serratì, Simona</creator><creator>Lapucci, Andrea</creator><creator>Chillà, Anastasia</creator><creator>Bazzichi, Laura</creator><creator>Bombardieri, Stefano</creator><creator>Kahaleh, Bashar</creator><creator>Calorini, Lido</creator><creator>Bianchini, Francesca</creator><creator>Fibbi, Gabriella</creator><creator>Del Rosso, Mario</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201008</creationdate><title>Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain–loss of function of pentraxin 3 and matrix metalloproteinase 12</title><author>Margheri, Francesca ; Serratì, Simona ; Lapucci, Andrea ; Chillà, Anastasia ; Bazzichi, Laura ; Bombardieri, Stefano ; Kahaleh, Bashar ; Calorini, Lido ; Bianchini, Francesca ; Fibbi, Gabriella ; Del Rosso, Mario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4552-346ef0076f549a18a26f97ae284ede68174cdcd321470b5b4a51531c8988c8b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>C-Reactive Protein - genetics</topic><topic>C-Reactive Protein - metabolism</topic><topic>Cell Movement - physiology</topic><topic>Cell Proliferation</topic><topic>Diseases of the osteoarticular system</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelium, Vascular - cytology</topic><topic>Endothelium, Vascular - metabolism</topic><topic>Humans</topic><topic>Matrix Metalloproteinase 12 - genetics</topic><topic>Matrix Metalloproteinase 12 - metabolism</topic><topic>Medical sciences</topic><topic>Neovascularization, Pathologic - metabolism</topic><topic>Neovascularization, Physiologic - physiology</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Scleroderma, Systemic - metabolism</topic><topic>Serum Amyloid P-Component - genetics</topic><topic>Serum Amyloid P-Component - metabolism</topic><topic>Transfection</topic><toplevel>online_resources</toplevel><creatorcontrib>Margheri, Francesca</creatorcontrib><creatorcontrib>Serratì, Simona</creatorcontrib><creatorcontrib>Lapucci, Andrea</creatorcontrib><creatorcontrib>Chillà, Anastasia</creatorcontrib><creatorcontrib>Bazzichi, Laura</creatorcontrib><creatorcontrib>Bombardieri, Stefano</creatorcontrib><creatorcontrib>Kahaleh, Bashar</creatorcontrib><creatorcontrib>Calorini, Lido</creatorcontrib><creatorcontrib>Bianchini, Francesca</creatorcontrib><creatorcontrib>Fibbi, Gabriella</creatorcontrib><creatorcontrib>Del Rosso, Mario</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arthritis and rheumatism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Margheri, Francesca</au><au>Serratì, Simona</au><au>Lapucci, Andrea</au><au>Chillà, Anastasia</au><au>Bazzichi, Laura</au><au>Bombardieri, Stefano</au><au>Kahaleh, Bashar</au><au>Calorini, Lido</au><au>Bianchini, Francesca</au><au>Fibbi, Gabriella</au><au>Del Rosso, Mario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain–loss of function of pentraxin 3 and matrix metalloproteinase 12</atitle><jtitle>Arthritis and rheumatism</jtitle><addtitle>Arthritis Rheum</addtitle><date>2010-08</date><risdate>2010</risdate><volume>62</volume><issue>8</issue><spage>2488</spage><epage>2498</epage><pages>2488-2498</pages><issn>0004-3591</issn><eissn>1529-0131</eissn><coden>ARHEAW</coden><abstract>Objective
Studies have shown that in systemic sclerosis (SSc) endothelial cells, overproduction of matrix metalloproteinase 12 (MMP‐12) and pentraxin 3 (PTX3) is associated with defective angiogenesis. This study was undertaken to examine whether overexpression of the relevant molecules could inhibit angiogenesis of normal microvascular endothelial cells (MVECs), and whether silencing of these molecules in SSc MVECs could restore the lost angiogenic properties of the cells in vitro and in vivo.
Methods
Transient transfection of MVECs with human MMP12 and PTX3 was performed by electroporation. Silencing of MMP12 and PTX3 was obtained by treatment with small interfering RNA, and treatment effects were validated by Western blotting with specific antibodies and a fluorimetric assay. In vitro cell migration and capillary morphogenesis were studied on Matrigel substrates. In vivo angiogenesis was studied using a Matrigel sponge assay in mice.
Results
Transfection of MMP12 and PTX3 in normal MVECs resulted in loss of proliferation, invasion, and capillary morphogenesis in vitro, attributed to truncation of the urokinase‐type plasminogen activator receptor by MMP12 and to the anti–fibroblast growth factor 2/anti–vascular endothelial growth factor activity of PTX3. These effects were particularly evident in mixed populations of transfected normal MVECs (50% transfected with MMP12 and 50% with PTX3). Silencing of the same molecules in SSc MVECs increased their invasion in Matrigel. Single‐gene silencing did not increase the capillary morphogenesis of SSc MVECs, whereas double‐gene–silenced cells showed a burst of capillary tube formation. Culture medium of silenced SSc MVECs stimulated angiogenesis in assays of Matrigel sponge invasion in mice.
Conclusion
Overexpression of either MMP12 or PTX3 in normal MVECs blunts their angiogenic properties. Loss of function of MMP12 and PTX3 in SSc MVECs restores the ability of the cells to produce capillaries in vitro and induces vascularization in vivo on a Matrigel sponge.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>20506099</pmid><doi>10.1002/art.27522</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0004-3591 |
ispartof | Arthritis and rheumatism, 2010-08, Vol.62 (8), p.2488-2498 |
issn | 0004-3591 1529-0131 |
language | eng |
recordid | cdi_proquest_miscellaneous_748940805 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Biological and medical sciences Blotting, Western C-Reactive Protein - genetics C-Reactive Protein - metabolism Cell Movement - physiology Cell Proliferation Diseases of the osteoarticular system Endothelial Cells - metabolism Endothelium, Vascular - cytology Endothelium, Vascular - metabolism Humans Matrix Metalloproteinase 12 - genetics Matrix Metalloproteinase 12 - metabolism Medical sciences Neovascularization, Pathologic - metabolism Neovascularization, Physiologic - physiology Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Scleroderma, Systemic - metabolism Serum Amyloid P-Component - genetics Serum Amyloid P-Component - metabolism Transfection |
title | Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain–loss of function of pentraxin 3 and matrix metalloproteinase 12 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T21%3A16%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulation%20of%20the%20angiogenic%20phenotype%20of%20normal%20and%20systemic%20sclerosis%20endothelial%20cells%20by%20gain%E2%80%93loss%20of%20function%20of%20pentraxin%203%20and%20matrix%20metalloproteinase%2012&rft.jtitle=Arthritis%20and%20rheumatism&rft.au=Margheri,%20Francesca&rft.date=2010-08&rft.volume=62&rft.issue=8&rft.spage=2488&rft.epage=2498&rft.pages=2488-2498&rft.issn=0004-3591&rft.eissn=1529-0131&rft.coden=ARHEAW&rft_id=info:doi/10.1002/art.27522&rft_dat=%3Cproquest_cross%3E748940805%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=748940805&rft_id=info:pmid/20506099&rfr_iscdi=true |